Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Azvudine and Paxlovid in High-risk Patients With COVID-19: A Prospective Randomized Controlled Trial

NCT05642910 is registered in ClinicalTrials.gov with Southeast University, China as lead sponsor.

NCT NCT05642910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05642910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Azvudine and Paxlovid in High-risk Patients With COVID-19: A Prospective Randomized Controlled Trial
Lead sponsor
Southeast University, China
Phase
Not applicable
Overall status
Unknown status
Start date
October 18, 2022
Completion date
April 30, 2023
Enrollment
540 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov-2 infection